Structure dependence of biological activities for primate cathelicidins

Journal of Peptide Science

Volumn 15, Issue 9, 2009, Pages 576-582

  Tomasinsig, Linda ^b   Morgera, Francesca ^a   Antcheva, Nikolinka ^a   Pacor, Sabrina ^a   Skerlavaj, Barbara ^b   Zanetti, Margherita ^b,c   Tossi, Alessandro ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF UDINE   (Italy)

^c National Laboratory CIB   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; PEPTIDE;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; BACTERIAL GROWTH; CONCENTRATION RESPONSE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOTOXICITY TEST; DRUG DETOXIFICATION; DRUG SCREENING; DRUG STRUCTURE; EUKARYOTIC CELL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; GROWTH INHIBITION; HUMAN; HUMAN CELL; MONKEY; NONHUMAN; ORANG UTAN; PRIORITY JOURNAL; RHESUS MONKEY; STRUCTURE ACTIVITY RELATION; TARGET CELL;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIA; CATHELICIDINS; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; HAPLORHINI; HEMOLYSIS; HUMANS; LIPOPOLYSACCHARIDES; MACACA MULATTA; MICE; MICROBIAL SENSITIVITY TESTS; NIH 3T3 CELLS; PONGO PYGMAEUS; PRIMATES;

EUKARYOTA; MACACA MULATTA; PONGO PYGMAEUS; POSIBACTERIA; PRIMATES;

EID: 70349645876     PISSN: 10752617     EISSN: 10991387     Source Type: Journal    
DOI: 10.1002/psc.1143     Document Type: Conference Paper

References (27)

1. Zasloff M. Antimicrobial peptides of multicellular organisms. Nature 2002; 415: 389-395.
2. Zanetti M. Cathelicidins, multifunctional peptides of the innate immunity. J. Leukoc. Biol. 2004; 75: 39-48.
3. Oppenheim JJ, Yang D. Alarmins: chemotactic activators of immune responses. Curr. Opin. Immunol. 2005; 17: 359-365.
4. Koczulla R, von Degenfeld G, Kupatt C, Krotz F, Zahler S, Gloe T, Issbrucker K, Unterberger P, Zaiou M, Lebherz C, Karl A, Raake P, Pfosser A, Boekstegers P, Welsch U, Hiemstra PS, Vogelmeier C, Gallo RL, Clauss M, Bals R. An angiogenic role for the human peptide antibiotic LL-37/hCAP-18. J. Clin. Invest. 2003; 111: 1665-1672.
5. Heilborn JD, Nilsson MF, Kratz G, Weber G, Sorensen O, Borregaard N, Stahle-Backdahl M. The cathelicidin anti-microbial peptide LL-37 is involved in re-epithelialization of human skin wounds and is lacking in chronic ulcer epithelium. J. Invest. Dermatol. 2003; 120: 379-389.
6. Mookherjee N, Rehaume LM, Hancock RE. Cathelicidins and functional analogues as antisepsis molecules. Expert Opin. Ther. Targets 2007; 11: 993-1004.
7. Rosenfeld Y, Papo N, Shai Y. Endotoxin (lipopolysaccharide) neutralization by innate immunity host-defense peptides. Peptide properties and plausible modes of action. J. Biol. Chem. 2006; 281: 1636-1643.
8. Cirioni O, Giacometti A, Ghiselli R, Bergnach C, Orlando F, Silvestri C, Mocchegiani F, Licci A, Skerlavaj B, Rocchi M, Saba V, Zanetti M, Scalise G. LL-37 protects rats against lethal sepsis caused by gram-negative bacteria. Antimicrob. Agents Chemother. 2006; 50: 1672-1679.
9. Sorensen O, Arnljots K, Cowland JB, Bainton DF, Borregaard N. The human antibacterial cathelicidin, hCAP-18, is synthesized in myelocytes and metamyelocytes and localized to specific granules in neutrophils. Blood 1997; 90: 2796-2803.
10. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, Kiessling R, Jornvall H, Wigzell H, Gudmundsson GH. The human antimicrobial and chemotactic peptides LL-37 and alpha-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000; 96: 3086-3093.
11. Frohm M, Agerberth B, Ahangari G, Stahle-Backdahl M, Liden S, Wigzell H, Gudmundsson GH, Frohm Nilsson M, Sandstedt B, Sorensen O, Weber G, Borregaard N, Stahle-Backdahl M. The expression of the gene coding for the antibacterial peptide LL-37 is induced in human keratinocytes during inflammatory disorders. J. Biol. Chem. 1997; 272: 15258-15263.
12. Frohm Nilsson M, Sandstedt B, Sorensen O, Weber G, Borregaard N, Stahle-Backdahl M. The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6. Infect. Immun. 1999; 67: 2561-2566.
13. Tossi A, Sandri L, Giangaspero A. 3: Amphipathic, alpha-helical antimicrobial peptides. Biopolymers 2000; 55: 4-30.
14. Johansson J, Gudmundsson GH, Rottenberg ME, Berndt KD, Agerberth B. Conformation-dependent antibacterial activity of the naturally occurring human peptide LL-37. J. Biol. Chem. 1998; 273: 3718-3724.
15. Zelezetsky I, Pontillo A, Puzzi L, Antcheva N, Segat L, Pacor S, Crovella S, Tossi A. Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. J. Biol. Chem. 2006; 281: 19861-19871.
16. Morgera F, Vaccari L, Antcheva N, Scaini D, Pacor S, Tossi A. Primate cathelicidin orthologues display different structures and membrane interactions. Biochem. J. 2008; 417: 727-735.
17. Tennessen JA. Molecular evolution of animal antimicrobial peptides: widespread moderate positive selection. J. Mol. Evol. 2005; 61: 445-455.
18. Bowdish DM, Davidson DJ, Lau YE, Lee K, Scott MG, Hancock RE. Impact of LL-37 on anti-infective immunity. J. Leukoc. Biol. 2005; 77: 451-459.
19. Bowdish DM, Davidson DJ, Hancock RE. A re-evaluation of the role of host defence peptides inmammalian immunity. Curr. Protein Pept. Sci. 2005; 6: 35-51.
20. Tomasinsig L, Pizzirani C, Skerlavaj B, Pellegatti P, Gulinelli S, Tossi A, Virgilio FD, Zanetti M. The human cathelicidin LL-37 modulates the activities of the P2X7 receptor in a structure-dependent manner. J. Biol. Chem. 2008; 283: 30471-30481.
21. Morgera F, Vaccari L, Creatti L, Antcheva N, Tossi A. In Membrane-active Peptides: Methods and Results on Structure and Function, Castanho M (ed.) IUL Publishers (International University Line): La Jolla, California, USA, 2009.
22. Rosenfeld Y, Sahl HG, Shai Y. Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides. Biochemistry 2008; 47: 6468-6478.
23. Giacometti A, Cirioni O, Ghiselli R, Mocchegiani F, D'Amato G, Circo R, Orlando F, Skerlavaj B, Silvestri C, Saba V, Zanetti M, Scalise G. Cathelicidin peptide sheep myeloid antimicrobial peptide-29 prevents endotoxin-induced mortality in rat models of septic shock. Am. J. Respir. Crit. Care Med. 2004; 169: 187-194.
24. Chen YH, Yang JT, Chau KH. Determination of thehelixandbeta form of proteins in aqueous solution by circular dichroism. Biochemistry 1974; 13: 3350-3359.
25. Giangaspero A, Sandri L, Tossi A. Amphipathic alpha helical antimicrobial peptides. Eur. J. Biochem. 2001; 268: 5589-5600.
26. Turner J, Cho Y, Dinh NN, Waring AJ, Lehrer RI. Activities of LL-37, a cathelin-associated antimicrobial peptide of human neutrophils. Antimicrob. Agents Chemother. 1998; 42: 2206-2214.
27. Wagschal K, Tripet B, Lavigne P,Mant C, Hodges RS. De novo design of a model peptide sequence to examine the effects of single amino acid substitutions in the hydrophobic core on both stability and oligomerization state of coiled-coils. Protein Sci. 1999; 8: 2312-2329.